Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease

Respirology

Volumn 16, Issue 6, 2011, Pages 939-946

  Van Gestel, Arnoldus J R ^a,b,c   Kohler, Malcolm ^b   Steier, Jörg ^d,e   Teschler, Sebastian ^a   Russi, Erich W ^b   Teschler, Helmut ^a  

^a RUHRLANDKLINIK   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c ZURICH UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

cardiac autonomic dysfunction; Chronic Respiratory Disease Questionnaire; health related quality of life; heart rate variability; parasympathetic tone

Indexed keywords

C REACTIVE PROTEIN; CARBON MONOXIDE;

AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASE; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PARASYMPATHETIC TONE; PRIORITY JOURNAL; QUALITY OF LIFE; STRUCTURED QUESTIONNAIRE;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; FEMALE; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 79960821044     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.01992.x     Document Type: Article

References (65)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Chron. Respir. Dis. 2010; 7: 131-3.
2. Hajiro T, Nishimura K, Tsukino M,. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir. Med. 2000; 94: 841-6.
3. Gudmundsson G, Gislason T, Janson C,. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries. Respir. Med. 2006; 100: 87-93. (Pubitemid 43033384)
4. Antonelli-Incalzi R, Imperiale C, Bellia V,. Do GOLD stages of COPD severity really correspond to differences in health status? Eur. Respir. J. 2003; 22: 444-9. (Pubitemid 37114938)
5. Carrasco Garrido P, de Miguel Diez J, Rejas Gutierrez J,. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual. Life Outcomes 2006; 4: 31. doi:10.1186/1477-7525-4-31. (Pubitemid 44018134)
6. Ferrer M, Alonso J, Morera J,. Chronic obstructive pulmonary disease stage and health-related quality of life. The quality of life of chronic obstructive pulmonary disease study group. Ann. Intern. Med. 1997; 127: 1072-9. (Pubitemid 28012076)
7. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, et al,. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006; 130: 1117-28. (Pubitemid 44583743)
8. StAhl E, Lindberg A, Jansson SA, et al,. Health-related quality of life is related to COPD disease severity. Health Qual. Life Outcomes 2005; 3: 56. doi:10.1186/1477-7525-3-56. (Pubitemid 41529215)
9. Habraken JM, ter Riet G, Gore JM, et al,. Health-related quality of life in end-stage COPD and lung cancer patients. J. Pain Symptom Manage. 2009; 37: 973-81.
10. StAhl E, Jansson SA, Jonsson AC, et al,. Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual. Life Outcomes 2003; 6: 1-18.
11. Ketelaars CAJ, Schlosser MAG, Mostert R, et al,. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 39-43. (Pubitemid 26048724)
12. Okubadejo AA, Jones PW, Wedzicha JA,. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 1996; 51: 44-7. (Pubitemid 26048725)
13. Mahler DA, Tomlison D, Olmstead EM, et al,. Changes in dyspnoea, health status and lung function in chronic airway disease. Am. J. Respir. Crit. Care Med. 1995; 151: 61-5.
14. Gonzalez E, Herrejon A, Inchaurraga I, et al,. Determinants of health-related quality of life in patients with pulmonary emphysema. Respir. Med. 2005; 99: 638-44. (Pubitemid 40468513)
15. Stein PK, Nelson P, Rottman JN, et al,. Heart rate variability reflects severity of COPD in PiZ α1-antitrypsin deficiency. Chest 1998; 113: 327-33. (Pubitemid 28110006)
16. Stewart AG, Waterhouse JC, Howard P,. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur. Respir. J. 1991; 4: 1207-14.
17. Volterrani M, Scalvini S, Mazzuero G,. Decreased heart rate variability in patients with chronic obstructive pulmonary disease. Chest 1994; 106: 1432-7. (Pubitemid 24346104)
18. Steward RI, Lewis M,. Cardiac output during exercise in patients with COPD. Chest 1986; 89: 199-205.
19. Carney RM, Blumenthal JA, Stein PK, et al,. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024-8. (Pubitemid 33027041)
20. Carney RM, Freedland FE,. Depression and heart rate variability in patients with coronary heart disease. Cleve. Clin. J. Med. 2009; 76: 13-17.
21. Roose SP, Dalack GW,. Treating the depressed patient with cardiovascular problems. J. Clin. Psychiatry 1992; 53 (Suppl.): 25-31.
22. Miller MR, Hankinson J, Brusasco V, et al,. Series 'ATS/ERS task force: standardisation of lung function testing': standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-38.
23. Miller MR, Crapo R, Hankinson J, et al,. General considerations for lung function testing. Eur. Respir. J. 2005; 26: 153-61. (Pubitemid 40945944)
24. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-17.
25. Kroidl RF, Schwarz S, Lehnigk B,. Kursbuch Spiroergometrie. Georg Thieme Verlag, Stuttgart, 2007.
26. Guyatt GH, Pugsley SO, Sullivan MJ, et al,. Effect of encouragement on walking test performance. Thorax 1984; 39: 818-22. (Pubitemid 14022730)
27. Troosters T, Gosselink R, Decramer M,. Six minute walking distance in healthy elderly subjects. Eur. Respir. J. 1999; 14: 270-4. (Pubitemid 29461288)
28. Guyatt GH, Berman LB, Townsend M, et al,. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-8. (Pubitemid 17142007)
29. Reda AA, Kotz D, Kocks JWH, et al,. Reliability and validity of the clinical COPD questionnaire and chronic respiratory questionnaire. Respir. Med. 2010; 104: 1675-82.
30. Rimoldi O, Pierini S, Ferrari A,. Analysis of short-term oscillations of R-R and arterial pressure in conscious dogs. Am. J. Physiol. 1990; 258: 967-76.
31. Stein PK, Kleiger RE,. Insights from the study of heart rate variability. Annu. Rev. Med. 1999; 50: 249-61. (Pubitemid 29117065)
32. Stein PK,. Inferring vagal tone from heart rate variability. Psychosom. Med. 1994; 56: 577-8. (Pubitemid 24373679)
33. Markus KU,. Herzschlaglängenfolgen während Taktatmung als Marker der kardiorespiratorischen Innervation. INAUGURAL-DISSERTATION Fachbereich Humanmedizin der Rheinisch-Westfälischen Technischen Hochschule Aachen. 2003: 9.
34. American Heart Association. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur. Heart J. 1996; 17: 354-81.
35. Persson PB,. Modulation of cardiovascular control mechanisms and their interaction. Physiol. Rev. 1996; 76: 193-244. (Pubitemid 26048282)
36. Butler GC, Naughton MT, Rahman MA, et al,. Continuous positive airway pressure increases heart rate variability in congestive heart failure. J. Am. Coll. Cardiol. 1995; 25: 672-9.
37. Williams J, Singh SJ, Morgan MDL,. Respiratory questionnaires in COPD. Thorax 2000; 55: 439.
38. Traver GA,. Measures of symptoms and life quality to predict emergent use of institutional health care resources in chronic obstructive airways disease. Heart Lung 1988; 17: 689-97. (Pubitemid 19006651)
39. Osman LM, Godden DJ, Friend JRA, et al,. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52: 67-71. (Pubitemid 27047228)
40. Oga T, Nishimura K, Tsukino M, et al,. T Health status measured with the CRQ does not predict mortality in COPD. Eur. Respir. J. 2002; 20: 1147-51. (Pubitemid 35331871)
41. Elkington H, White P, Addington-Hall J, et al,. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat. Med. 2005; 19: 485-91. (Pubitemid 41430822)
42. Jones I, Kirby A, Ormiston P,. The needs of patients dying of chronic obstructive pulmonary disease in the community. Fam. Pract. 2004; 21: 310-13. (Pubitemid 38765309)
43. Robinson T,. Living with severe hypoxic COPD: the patients' experience. Nurs. Times 2005; 101: 38-42.
44. Seamark DA, Blake SD, Seamark CJ, et al,. Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their careers. An interpretative phenomenological analysis. Palliat. Med. 2004; 18: 619-25. (Pubitemid 39468109)
45. Skilbeck J, Mott L, Page H, et al,. Palliative care in chronic obstructive airways disease: a needs assessment. Palliat. Med. 1998; 12: 245-54. (Pubitemid 28344638)
46. Hynninen KMJ, Breitve MH, Wiborg AB, et al,. Psychological characteristics of patients with chronic obstructive pulmonary disease: a review. J. Psychosom. Res. 2005; 59: 429-43. (Pubitemid 41676902)
47. McSweeny AJ, Grant I, Heaton RK, et al,. Life quality of patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 1982; 142: 473-8. (Pubitemid 12190735)
48. Engel GL,. The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129-36. (Pubitemid 8067676)
49. Barnes PJ,. Neural control of human airways in health and disease. Am. Rev. Respir. Dis. 1986; 134: 1289-314. (Pubitemid 17216914)
50. De Jongste JC, Jongejan RC, Kerrebijn KF,. Control of airway caliber by autonomic nerves in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 1991; 43: 1421-6.
51. Cohen H, Benjamin J, Geva AB, et al,. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res. 2000; 96: 1-13.
52. Cohen H, Matar AM, Kaplan Z, et al,. Analysis of heart rate variability in posttraumatic stress disorder patients in response to a trauma-related reminder. Biol. Psychiatry 1998; 44: 1054-9. (Pubitemid 28545234)
53. Cohen H, Matar AM, Kaplan Z, et al,. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Biol. Psychiatry 2000; 96: 1-13.
54. Balogh S, Fitzpatrick DF, Hendricks SE, et al,. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol. Bull. 1993; 29: 201-6. (Pubitemid 23311525)
55. Carney RM, Freedland KE, Stein PK, et al,. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom. Med. 2000; 62: 639-47.
56. Khaykin Y, Dorian P, Baker B, et al,. Autonomic correlates of antidepressant treatment using heart-rate variability analysis. Can. J. Psychiatry 1998; 43: 183-6. (Pubitemid 28168994)
57. McFarlane A, Kamath MV, Fallen EL, et al,. Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction. Am. Heart J. 2001; 142: 617-23. (Pubitemid 32900487)
58. Camillo CA, Pitta F, Possani HV, et al,. Heart rate variability and disease characteristics in patients with COPD. Lung 2008; 186: 393-401.
59. Kuo TB, Lin T, Yang CC, et al,. Effect of aging on gender differences in neural control of heart rate. Am. J. Physiol. 1999; 277: 233-9.
60. Sinnreich R, Kark JD, Friedlander Y, et al,. Five minute recordings of heart rate variability for population studies: repeatability and age-sex characteristics. Heart 1998; 80: 156-62. (Pubitemid 28389477)
61. Thayer JF, Lane RD,. A model of neurovisceral integration in emotion regulation and dysregulation. J. Affect. Disord. 2000; 61: 201-16. (Pubitemid 32119267)
62. Suh S,. Stress, anxiety, and heart rate variability in chronic obstructive pulmonary disease. Dissertation Ohio State University, 2010.
63. Bhattacharyya MR, Whitehead DL, Rakhit R, et al,. Depressed mood, positive affect, and heart rate variability in patients with suspected coronary artery disease. Psychosom. Med. 2008; 70: 1020-7.
64. Thayer JF, Friedman BH,. A neurovisceral integration model of health disparities in aging. Critical Perspectives on Racial and Ethnic Differences in Health in Late Life 2004: 15.
65. Rutten FH, Zuithoff NP, Hak E, et al,. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 2010; 170: 880-7.